PHARMACEUTICAL COMPOSITIONS COMPRISING BISPECIFIC ANTIBODIES DIRECTED AGAINST CD3 AND CD20 AND THEIR USES

The present invention relates to improved pharmaceutical compositions and dosage unit forms of bispecific CD3×CD20 antibodies and to routes of administration.

Saved in:
Bibliographic Details
Main Authors CIMANDER, Christian, BJERREGAARD, Bolette, WAHLBOM, Maria Anna Cecilia, MADSEN, Peter Juul, JENSEN, Mette Hamborg, CLAUSEN, Jacob Dahlqvist, HARLOW, Lene Schantz, VALBJOERN, Jesper, PASS, Jesper, REN, Shan
Format Patent
LanguageEnglish
Published 29.12.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to improved pharmaceutical compositions and dosage unit forms of bispecific CD3×CD20 antibodies and to routes of administration.
Bibliography:Application Number: US202017635258